Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity

Por Counts, Scott E., Mufson, Elliott J.
Publicado em 2010

PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT

Por Counts, Scott E., Mufson, Elliott J.
Publicado em 2010

Multi-Infarct Dementia: A Historical Perspective

Por McKay, Erin, Counts, Scott E.
Publicado no Dement Geriatr Cogn Dis Extra (2017)

Regulator of Cell Cycle (RGCC) Expression during the Progression of Alzheimer's Disease

Por Counts, Scott E., Mufson, Elliott J.
Publicado no Cell Transplant (2017)

Overview of Immunotherapy in Alzheimer’s Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD

Por Counts, Scott E., Lahiri, Debomoy K.
Publicado no Curr Alzheimer Res (2014)

Oxytocin Receptor Signaling in Vascular Function and Stroke

Por McKay, Erin C., Counts, Scott E.
Publicado no Front Neurosci (2020)

Vascular cognitive impairment and dementia

Por Gorelick, Philip B., Counts, Scott E., Nyenhuis, David
Publicado no Biochim Biophys Acta (2015)

Evidence for Mitochondrial UPR Gene Activation in Familial and Sporadic Alzheimer’s Disease

Por Beck, John S., Mufson, Elliott J., Counts, Scott E.
Publicado no Curr Alzheimer Res (2016)

Pontine Arteriolosclerosis and Locus Coeruleus Oxidative Stress Differentiate Resilience from Mild Cognitive Impairment in a Clinical Pathologic Cohort

Por Kelly, Sarah C, Nelson, Peter T, Counts, Scott E
Publicado no J Neuropathol Exp Neurol (2021)

Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment

Por Weinberg, Rebecca B., Mufson, Elliott J., Counts, Scott E.
Publicado no Front Neurosci (2015)

Preservation of cortical sortilin protein levels in MCI and Alzheimer’s disease

Por Mufson, Elliott J., Wuu, Joanne, Counts, Scott E., Nykjaer, Anders
Publicado em 2010

Gender differences in NGF receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer’s disease

Por Counts, Scott E., Che, Shaoli, Ginsberg, Stephen D., Mufson, Elliott J.
Publicado em 2011

Single cell gene expression profiling in Alzheimer’s disease

Por Ginsberg, Stephen D., Che, Shaoli, Counts, Scott E., Mufson, Elliott J.
Publicado em 2012

Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease

Por Tiernan, Chelsea T, Mufson, Elliott J, Kanaan, Nicholas M, Counts, Scott E
Publicado no J Neuropathol Exp Neurol (2018)

Intravenous Immunoglobulin Reduces Tau Pathology and Preserves Neuroplastic Gene Expression in the 3xTg Mouse Model of Alzheimer’s Disease

Por Counts, Scott E., Perez, Sylvia E., He, Bin, Mufson, Elliott J.
Publicado no Curr Alzheimer Res (2014)

Cholinergic system during the progression of Alzheimer's disease: therapeutic implications

Por Mufson, Elliott J, Counts, Scott E, Perez, Sylvia E, Ginsberg, Stephen D
Publicado em 2008

Neuroprotective Role for Galanin in Alzheimer’s Disease

Por Counts, Scott E., Perez, Sylvia E., Ginsberg, Stephen D., Mufson, Elliott J.
Publicado em 2010

Galanin Hyperinnervation Upregulates Choline Acetyltransferase Expression in Cholinergic Basal Forebrain Neurons in Alzheimer's Disease

Por Counts, Scott E., He, Bin, Che, Shaoli, Ginsberg, Stephen D., Mufson, Elliott J.
Publicado em 2008

Galanin Fiber Hyperinnervation Preserves Neuroprotective Gene Expression in Cholinergic Basal Forebrain Neurons in Alzheimer’s Disease

Por Counts, Scott E., He, Bin, Che, Shaoli, Ginsberg, Stephen D., Mufson, Elliott J.
Publicado em 2009

Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

Por Fonseca, Maria I, McGuire, Susan O, Counts, Scott E, Tenner, Andrea J
Publicado em 2013